Camlin Fine Sciences Ltd

532834

Summary

Fair Value Assessment
Overvalued (27% Premium)
Fair ValueQ237.58UncertaintyHigh
Close Price302.25Jun 23, 2025
Price Down by |%
Chart Data Not Available

Business Description
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.
Contact
CST Road, Kalina Floor 2 to 5, In GS Point, Mumbai, MH 400 098
T +91 2267001000
www.camlinfs.com opens in a new tab
Sector
Basic Materials
Industry
Specialty Chemicals
Most Recent Earnings
Mar 31, 2025
Fiscal Year End
Mar 31, 2025
Employees
1,289

Key Metrics

Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Income Statement (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Revenue
16.67 16.67 15.95 16.71 14.04 11.71
Revenue Growth %
14.62% 14.62% -4.56% 19.00% 19.92% 15.06%
Gross Profit
8.17 8.17 6.58 8.41 6.36 5.77
Gross Profit Margin %
49.04% 49.04% 41.27% 50.32% 45.25% 49.24%
Operating Income
1.44 1.44 0.71 1.60 1.06 1.58
Operating Margin %
8.66% 8.66% 4.47% 9.57% 7.55% 13.48%
EBIT
1.73 1.73 -0.33 1.18 1.22 1.43
EBIT Margin %
10.38% 10.38% -2.09% 7.08% 8.69% 12.22%
EBITDA
2.47 2.47 0.45 1.81 1.78 1.87
EBITDA Margin %
14.80% 14.80% 2.83% 10.82% 12.68% 16.01%
Net Income
-1.39 -1.39 -0.93 0.52 0.61 0.51
Net Profit Margin %
2.96% 2.96% -6.58% 2.38% 4.30% 5.58%
Basic EPS
-8.03 -8.03 -5.45 3.37 4.54 4.03
Diluted EPS
-8.03 -8.03 -5.45 3.33 4.45 3.60
Normalized EPS
Total Dividends per Share
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Balance Sheet (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Total Assets
20.24 20.24 19.52 20.60 18.00 14.82
Total Liabilities
11.49 11.49 10.95 12.36 10.35 7.68
Total Debt
6.81 6.81 6.83 8.01 6.46 5.50
Total Equity
8.75 8.75 8.57 8.24 7.65 7.13
Cash And Cash Equivalents
1.04 1.04 0.80 0.94 1.08 0.76
Working Capital
3.37 3.37 2.68 2.95 2.98 3.17
Shares Outstanding (Mil)
171.45 171.41 160.79
Book Value Per Share
47.98 47.98 48.46 49.86 45.58 45.15
Total Debt To Equity
0.78 0.78 0.80 0.97 0.84 0.77
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Cash Flow Statement (in Bil, except ratios)
03/31/2025
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
0.27 1.39 0.51 1.45 1.17 0.86
Cash From Investing Activities
-0.75 -0.66 -1.25 -2.49 -1.33 -0.90
Cash From Financing Activities
0.72 -0.86 0.60 1.36 0.39 0.03
Capital Expenditures
0.42 0.61 1.44 2.14 0.84 1.34
Free Cash Flow
-0.07 -0.26 -0.07 -1.00 0.51 -0.47
Change in Cash
0.24 -0.13 -0.14 0.32 0.23 -0.01

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
Oops!
Something went wrong.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
Oops!
Something went wrong.

Ownership

Ownership lists the Fund owners and Intitutional owners of the stock.
Name
Morningstar
Rating
% Total
Shares Held
% Total
Assets
Trend
Prev. 8 Qtrs
Current Shares
Change Amount
Change %
Date
Buoyant Opportunities Strategy Not Rated 3.42 2.27 6,418,134
59,433
0.93%
Apr 30, 2025
ICICI Pru Commodities Reg Gr Not Rated 0.83 1.32 1,559,089
57,269
3.81%
May 31, 2025
JM Aggressive Hybrid Gr 0.43 2.31 816,343
-30,000
3.54%
May 31, 2025
JM Small Cap Reg Gr Not Rated 0.43 2.58 800,860
70,000
9.58%
May 31, 2025
IMC Emerging Markets Small Cap 0.41 0.70 777,651
777,651
May 31, 2025
Total (for Top 5) 5.52 10,372,077
934,353

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top